Phase I trial of myeloablative conditioning with 3-day total marrow and lymphoid irradiation for leukemia.
Ogawa H, Konishi T, Najima Y, Kito S, Hashimoto S, Kato C, Sakai S, Kanbara Y, Atsuta Y, Konuma R, Wada A, Murakami D, Nakasima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Shingai N, Toya T, Shimizu H, Kobayashi T, Ohashi K, Doki N, Murofushi KN.
Ogawa H, et al. Among authors: ohashi k.
Cancer Sci. 2023 Feb;114(2):596-605. doi: 10.1111/cas.15611. Epub 2022 Nov 2.
Cancer Sci. 2023.
PMID: 36221800
Free PMC article.
Clinical Trial.